http://www.fpnotebook.com/
Cellulitis
Aka: Cellulitis, Staphylococcal Cellulitis, Streptococcal Cellulitis
- See Also
- Skin Infection
- Hand Infection
- Nodular Lymphangitis
- Erysipelas
- Impetigo
- Preseptal Cellulitis and Periorbital Cellulitis
- Cellulitis in Diabetes Mellitus
- Risk factors
- Also see Group A Streptococcus Cellulitis (Erysipelas)
- Trauma
- Laceration
- Puncture Wound
- Post-operative infection at incision site
- Underlying skin lesion
- Superficial Folliculitis or Furuncle (Staphylococcus infection)
- Skin Ulcer
- Fungal Dermatoses
- Non-Group A Streptococcus Cellulitis related lesions
- Coronary Artery bypass with saphenous vein graft
- Radical pelvic surgery or radiation
- Neoplasms
- Lymphatic Cutaneous metastases from neoplasms
- Inflammatory Breast Cancer
- Carcinoma Erysipeloides
- Extremity Stasis or Edema
- Chronic Dependent edema (may progress rapidly)
- Peripheral Vascular Disease
- Perianal Streptococcal Cellulitis (in children)
- Diabetes Mellitus
- See Cellulitis in Diabetes Mellitus
- Immunocompromised patients
- Causes: General
- Common (most Cellulitis cases)
- Staphylococcal Cellulitis
- Group A Streptococcus Cellulitis (Erysipelas)
- Less common Streptococcal infections
- Pneumococcus
- Non-Group A Streptococcus Cellulitis
- Group C or G Streptococcus Cellulitis
- Group B Streptococcus Cellulitis in newborns
- Rapidly progressive Cellulitis
- See Necrotizing Fasciitis
- Vibrio Cellulitis (Vibrio vulnificus)
- Clostridium perfringens
- Pasteurella multocida
- Aeromonas Hydrophila
- Causes: Exposure
- Fish Handlers or water exposure (See Marine Trauma)
- Erysipelothrix rhusiopathiae (Erysipeloid)
- Mycobacterium marinum (Fish tank exposure)
- Aeromonas Hydrophila
- Vibrio Cellulitis
- Animal Bites
- Cat Bites
- Pasteurella multocida
- Dog Bites
- Staphylococcus intermedius
- Envenomation spines of stonefish (South Pacific)
- Risk of serious systemic toxicity, pulmonary edema
- Human Bites
- See Fight Bite
- Miscellaneous
- Pseudomonas aeruginosa
- Sweaty Tennis Shoe Syndrome
- Eosinophilic Cellulitis
- Immunocompromised Patients
- Serratia
- Proteus
- Enterobacteriaceae
- Cryptococcus
- Legionella pneumophila
- Associated with Legionella pneumonia
- Legionella micdadei
- Seen in renal transplant patients
- Escherichia coli
- Seen in children with relapsing Nephrotic Syndrome
- Symptoms
- Inflamed skin wound develops rapidly days after injury
- Local tenderness
- Pain
- Very red, hot, swollen an painful
- Associated symptoms
- Malaise
- Fever, chills
- Signs
- Draw margins of erythema with marker
- Follow course of infection on antibiotics
- Wound with contiguous inflammation
- Erythema (Rubor)
- Swelling (Tumor)
- Local tenderness (Dolor)
- Warm to touch (Calor)
- Abscess
- Hallmark of Staphylococcus aureus
- Regional spread
- Ascending lymphangitis
- Regional Lymphadenopathy
- Small patches of necrosis
- Gram Negative superinfection may also be present
- Hemorrhagic and necrotic bullae (specific conditions)
- Group A Streptococcal Cellulitis
- Pseudomonas Cellulitis
- Vibrio Cellulitis (Vibrio vulnificus)
- Clostridium perfringens
- Aeromonas Hydrophila
- Differential Diagnosis: Non-infectious Conditions
- Vascular Conditions
- Superficial Thrombophlebitis
- Deep Vein Thrombosis
- Dermatologic Conditions
- Contact Dermatitis
- Insect Bites
- Acute Drug Reaction
- Eosinophilic Cellulitis
- Sweet Syndrome
- Rheumatologic Conditions
- Gouty Arthritis
- Relapsing Polychondritis
- Miscellaneous
- Erythromelalgia
- Inflammatory Carcinoma (metastatic cancer to skin)
- Foreign body reaction (mesh, metal, silicone implant)
- Familial Mediterranean fever
- References
- Vergidis (2005) Ann Intern Med 142:47-55
- Labs
- Blood Culture (25% sensitivity)
- Skin biopsy (25% sensitivity)
- Fine Needle Aspiration
- Saline injection and aspiration
- Listed for historical purposes only (rarely done in clinical practice)
- Technique
- Leading edge injection and aspiration with saline
- Efficacy
- May assist diagnosis with Cellulitis
- Not useful in Erysipelas
- 30% sensitivity from closed lesions (efficacy may be as low as 5%)
- Indication
- Unusual pathogens suspected
- Cellulitis refractory to current antibiotics
- Imaging
- Soft tissue Ultrasound
- Abcess formation is consistent with staphylococcal infection
- Management: General Care
- Tetanus prophylaxis
- Immobilization and elevation of involved limb
- Splint in a position of function
- Decreases swelling
- Clean wound site
- Copious irrigation
- Debride devitalized tissue
- Incision and Drainage if deep fluctuant pocket
- Compresses
- Cool sterile saline dressings decrease pain
- Later, moist heat helps localize infection
- Management: Factors affecting antibiotic selection and course
- Distinguish Erysipelas, abscess and Cellulitis
- Erysipelas (superficial)
- Sharply demarcated, bright red, indurated
- Typically caused by Group A Streptococcus
- Cellulitis (deep, subcutaneous)
- Abrupt onset of indistinct faint erythema with rapidly advancing border
- Typically caused by group A. Streptococcus or Group G (although Staphylococcus can cause this as well)
- Abscess
- Hallmark of Staphylococcus aureus infection
- Primary management is Incision and Drainage
- If antibiotics are needed (Cellulitis with abscess), then cover MRSA (see below)
- Other bacterial Skin Infections
- Folliculitis
- Impetigo
- Distinguish most likely organism: Streptococcus or Staphylococcus
- Streptococcus (especially Group A Streptococcus)
- Streptococcus (especially Group A) is the most common cause of Cellulitis and Erysipelas
- Abrupt onset with rapid spread
- May be associated with fever and ascending lymphangitis
- Typically associated with an inciting skin injury with associated break in the skin (e.g. Tinea Pedis)
- Staphylococcus (typically MRSA)
- Less common cause of Cellulitis
- Typically presents without a primary skin injury site
- Primary source is often a Folliculitis
- Abscess is often present (Incision and Drainage is primary treatment)
- Consider soft tissue Ultrasound if suspect occult abscess
- Consider Antibiotic Resistance
- Avoid Fluoroquinolones in Cellulitis due to high resistance
- Staphylococcus aureus infections are often due to MRSA
- Course
- Standard course has been 10 days of antibiotics
- New: 5 day as effective as 10 day if uncomplicated
- Hepburn (2004) Arch Intern Med 164:1669-74
- Management: Extremity Infections (non-diabetic patients)
- See Skin Infections in Diabetes Mellitus
- Erysipelas (well demarcated and bright red): Streptococcus coverage
- Treat as Cellulitis with broader coverage unless classic Erysipelas appearance
- Mild-Moderate infections (oral, oupatient management)
- Penicillin VK 500 mg orally four times per day for 7-10 days or
- Amoxicillin 500 mg orally three times per day for 7-10 days or
- Cephalexin 500 mg orally four times per day for 7-10 days
- Penicillin Allergy
- Azithromycin 500 mg orally on day 1, then 250 mg orally on days 2-5
- Clindamycin 300 mg orally four times per day for 7-10 days
- Severe infections (requiring IV antibiotics)
- Penicillin G 2 million units IV every 6 hours or
- Cefazolin 1 gram IV every 8 hours or
- Clindamycin 600 mg IV every 8 hours or
- Vancomycin 15 mg/kg IV every 12 hours
- Cellulitis (less distinct margins): Streptococcus and Staphylococcus coverage
- First Line: Streptococcus (most likely) and MSSA coverage
- Oral
- Cephalexin 500 mg orally four times per day for 7-10 days or
- Dicloxacillin 500 mg orally four times per day for 7-10 days or
- Amoxicillin-Clavulanate (Augmentin) 875 mg orally twice per day for 7-10 days
- Parenteral (more severe infections)
- Cefazolin 1 gram IV every 8 hours or
- Nafcillin 2 grams IV q4 hours or
- Oxacillin 2 grams IV q4 hours
- Outpatient parenteral (adults, narrower spectrum parenteral protocol)
- Protocol: Both medications for 7-10 days
- Cefazolin 2 gram IV q24 hours AND
- Probenacid 1 gram PO q24 hours (Decreases Cefazolin excretion)
- References
- Grayson (2002) Clin Infect Dis 34:1440-8
- Second Line: Streptococcus and MRSA coverage
- Oral
- Septra DS 2-3 tabs twice daily WITH Penicillin, Amoxicillin, or Cephalexin (see dosing above) or
- Clindamycin 300 mg orally four times per day for 7-10 days or
- Linezolid 600 mg PO bid (very expensive)
- Parenteral (more severe infections)
- Vancomycin 15 mg/kg IV every 12 hours or
- Linezolid 600 mg IV q12 hours (very expensive) or
- Clindamycin 600 mg IV q8 hours
- Cellulitis with Abscess (or per Gram Stain): Staphylococcus coverage
- Incision and Drainage is primary treatment of abscess
- Antibiotics are not required if no Cellulitis is present
- Antibiotics are at the discretion of the provider and may be warranted despite lack of Cellulitis
- Serious comorbidity
- Unreliable follow-up
- Large abscess (e.g. 5 cm and greater)
- Antibiotic selection and course
- Antibiotic selection is the same as for abscess with Cellulitis (typically MRSA)
- Choose a single agent (esp. Septra)
- Course is brief (3-5 days)
- Staphylococcus Cellulitis present: MRSA coverage
- Septra DS 2-3 tabs twice daily or
- Clindamycin 300 mg orally four times per day for 7-10 days or
- Minocycline of Doxycycline 100 mg twice daily for 7-10 days or
- Linezolid 600 mg PO bid (very expensive)
- Severe infections
- Vancomycin 15 mg/kg IV every 12 hours
- Linezolid 600 mg IV q12 hours (very expensive)
- Management: Facial erysipelas
- Staphylococcus aureus may be difficult to exclude (despite most cases being Group A Streptococcus)
- Guidelines in 2012 recommend covering for MRSA
- Sanford guide recommends Vancomycin parenterally or Linezolid orally or IV
- Mild to moderate infections
- Clindamycin 300 mg orally four times per day or
- Augmentin high dose with Septra DS 2 tabs twice daily or
- Severe infections
- Vancomycin 15 mg/kg IV every 12 hours or
- Linezolid 600 mg IV q12 hours (very expensive)
- Management: Cellulitis in comorbid Diabetes Mellitus
- See Skin Infections in Diabetes Mellitus
- Prevention: Recurrent abscess
- Wash all sheets, towels and clothes after an episode
- Dispose of used razors
- Consider Antibacterial soap (e.g. Chlorhexidine)
- Consider Mupirocin (Bactroban) in nares twice daily for 5 days (decolonization)
- Prevention: Recurrent Cellulitis
- Reduce peripheral edema (support stockings)
- Good skin hygiene
- Prophylactic antibiotics:
- Efficacy
- Not useful if underlying predisposing condition
- No Penicillin Allergy
- Penicillin G 1.2 MU IM q4 weeks
- Penicillin V 250 mg PO bid
- Penicillin Allergic
- Erythromycin 500 mg PO qd
- Azithromycin 250 mg PO qd
- Clarithromycin 500 mg PO qd
- Complications:
- Thrombophlebitis in older patients
- Necrotizing Fasciitis
- References
- Gilbert (2011) Sanford Guide
- Moran in Majoewsky (2013) EM:Rap 13(2): 11
- Stulberg (2002) Am Fam Physician 66(1):119-24